Osteonecrosis in systemic lupus erythematosus patients;Osteonecrose em pacientes com lúpus eritematoso sistêmico

Revista Brasileira de Reumatologia

Volumn 45, Issue 1, 2005, Pages 1-8

  Claudio Sella, Elaine Marcelina ^a   Petronila De Carvalho, Maria Rosenilda ^a   Inoue Sato, Emilia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Osteonecrosis; Risk factors; Systemic lupus erythematosus; Vasculitis

Indexed keywords

PREDNISONE;

ADULT; ARTICLE; BONE NECROSIS; BONE SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MALE; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSIS; RISK FACTOR; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

EID: 33645453176     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sweet DE, Madewell JE: Osteonecrosis - Pathogenesis. In: Resnick D (ed.). Diagnosis of bone and joint disorders. 3rd ed., United States: WB Saunders Company, 1995 (section XV, chapter 79, p. 3445-94).
2. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME: Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32: 94-124, 2002.
3. Dubois EL, Cozen L: Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA 174: 966-71, 1960.
4. Gladman DD, Urowitz MB: Morbidity in systemic lupus erythematosus. J Rheumatol 14 (suppl 13): 223-6, 1987.
5. Weiner ES, Abeles M: Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus - a reevaluation. J Rheumatol 16: 604-8, 1989.
6. Aranow C, Zelicof S, Leslie D, et al: Clinically occult avascular necrosis of the hip in systemic lupus erythematosus. J Rheumatol 24: 2318-22, 1997.
7. Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M: Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 24: 654-62, 1997.
8. Mok CC, Lau CS, Wong RWS: Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol 37: 895-900, 1998.
9. Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V, Hallet DC, Cook RJ: Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol 28: 761-5, 2001.
10. Halland AM, Klemp P, Botes D, Van Heerden BB, Loxton A, Scher AT: Avascular necrosis of the hip in systemic lupus erythematosus - the role of magnetic resonance imaging. Br J Rheumatol 32: 972-6, 1993.
11. Houssiau FA, Toukap AN, Depresseux G, et al: Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus - lack of correlation with antiphospholipid antibodies. Br J Rheumatol 37: 448-53, 1998.
12. Gladman D, Ginzler E, Goldsmith C, et al: The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39: 363-9, 1996.
13. Gladman DD, Urowitz MB, Goldsmith CH, et al: The reliability of the systemic lupus international collaborating clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 40: 809-13, 1997.
14. Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB: Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med 79: 596-604, 1985.
15. Gladman DD, Chaudhry-Ahluwalia V, Ibañez D, Bogoch E, Urowitz MB: Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. J Rheumatology 28: 2226-9, 2001.
16. Klippel JH, Gerber LH, Pollak L, Deker JL: Avascular necrosis in systemic lupus erythematosus. Am J Med 67: 83-7, 1979.
17. Mok MY, Farewell VT, Isenberg DA: Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus - is there a role for antiphospholipid antibodies? Ann Rheum Dis 59: 462-7, 2000.
18. Sheikh JS, Retzinger GS, Hess EV: Association of osteonecrosis in systemic lupus erythematosus with abnormalities of fibrinolysis. Lupus 7: 42-8, 1998.
19. Jones LC, Mont MA, Le TB, et al: Procoagulants and osteonecrosis. J Rheumatology 30: 783-91, 2003.
20. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-7, 1982.
21. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997 (letter).
22. Siegel J: Estatística não-paramétrica, Brasil, McGraw Hill do Brasil, 1981, 350p.
23. Urowitz MB, Gladman DD: How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology 39: 238-44, 2000.
24. Sella EMC, Sato EI: Avaliação do índice de danos permanentes através de SLICC/ACR-DI em pacientes com mais de cinco anos de diagnóstico de lúpus eritematoso sistêmico. Rev Bras Reumatol 44: 115-22, 2004.
25. Costallat LTL, Coimbra AMV: Lúpus eritematoso sistêmico - análise clínica e laboratorial de 272 pacientes em um hospital universitario (1973-1992). Rev Bras Reumatol 35: 23-9, 1995.
26. Rascu A, Manger K, Kraetsch HG, Kalden JR, Manger B: Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation? Lupus 5: 323-7, 1996.
27. Oinuma K, Harada Y, Nawata Y, et al: Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis 60: 1145-8, 2001.
28. Mont MA, Fairbank AC, Petri M, Hungerford DS: Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus. Clin Orthop 334: 91-7, 1997.
29. Maxwell SRJ, Moots RJ, Kendall MJ: Corticosteroids - do they damage the cardiovascular system? Postgrad Med 70: 863-70, 1994.
30. American College of Rheumatology Ad Hoc Committee on systemic lupus erythematosus guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 42: 1785-96, 1999.
31. Chaudhry-Ahlawalia V, Gladman DD, Urowitz MB, Bogoch E, Farewell VT: Radiographic reports in osteonecrosis of the hip in systemic lupus erythematosus. Clin Orthop 352: 131-6, 1998.
32. Nagasawa K, Tsukamoto H, Tada Y, et al: Imaging study on the mode of development and changes in avascular necrosis of the femoral head in systemic lupus erythematosus - long-term observations. Br J Rheum 33: 343-7, 1994.
33. Sugano N, Ohzono K, Masuhara K, Takaoka K, Ono K: Prognostication of osteonecrosis in the femoral head in patients with systemic lupus erythematosus by magnetic resonance imaging. Clin Orthop 305: 190-9, 1994.
34. Mont MA, Jones LC: Management of osteonecrosis in systemic lupus erythematosus. Rheum Dis Clin North Am 26: 279-309, 2000.
35. Hanssen AD, Cabanela ME, Michet Jr CJ: Hip arthroplasty in patients with systemic lupus erythematosus. J Bone and Joint Surg 69-A: 807-14, 1987.
36. Zangger P, Gladman DD, Urowitz MB, Bogoch ER: Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus. J Rheumatol 27: 919-23, 2000.